Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 26497 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 28359 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 32425 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 35912 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 42308 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 43113 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 45863 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 56812 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 62185 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 81590 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 95801 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 147161 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 202448 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | Peak area normalized | female | diabetic | no neuropathy |